News

AddToAny

Google+ Facebook Twitter Twitter

DNA biosensor for low-cost diagnostics

A new biosensor chip that boasts an accurate and inexpensive design may increase accessibility to high-quality diagnostics, it is claimed. 

It identifies biomarkers by measuring how binding occurs between DNA strands and the device.

Its modular design lowers costs by making it easier to mass produce and allowing the most expensive components to be reused. 

Like other DNA biosensors, the device takes advantage of the fact that a single DNA strand, when not paired with another within the familiar double helix, is primed for chemical bonding. Part of the device is coated with single strands of DNA.

When these “probes” encounter DNA biomarkers that have a corresponding, or complementary, genetic sequence, the two strands bind, sending a signal that is picked up by the device.

bit.ly/3DsF3qW

Image credit | Shutterstock

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top